Geneos Wealth Management Inc. Atri Cure, Inc. Transaction History

Geneos Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $65,183 - $81,027	-1,135 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$63.4 - $87.14 $4,374 - $6,012	-69 Reduced 5.73%	1,135 $78,000
Q3 2021 Nov 09, 2021	BUY	$69.28 - $84.46 $4,780 - $5,827	69 Added 6.08%	1,204 $84,000
Q1 2018 Sep 07, 2021	BUY	$15.05 - $21.03 $17,081 - $23,869	1,135 New	1,135 $23,000

229

47.1M

25.8K

4.5K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.56B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.